SCHEMBL7624042

SCHEMBL7624042

NC(Cc1c[nH]cn1)C(=O)NCCc1c[nH]cn1

nearest known ligand 0.43

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
NLN Q9BYT8 3/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7624049 1.00 NLN (0.42) NLN
SCHEMBL14151247 0.93 NLN (0.39) NLN
SCHEMBL15398762 0.89 NLN (0.39) NLN
SCHEMBL8960512 0.89 NLN (0.37) NLN
SCHEMBL3000079 0.89 NLN (0.37) NLN
SCHEMBL13080959 0.87 DPP7 (0.38) NLN
Hydrochloric Acid SCHEMBL30401731 0.87 NLN (0.36) NLN
SCHEMBL23573011 0.87 NLN (0.47) NLN
SCHEMBL21794913 0.87 NLN (0.47) NLN
SCHEMBL13073718 0.87 NLN (0.47) NLN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6448282-B1 H3 HISTAMINE RECEPTOR ANTAGONIST ACTIVITY; ALLERGY, INFLAMMATION, CARDIOVASCULAR DISEASE, DEPRESSION, SCHIZOPHRENIA, NARCOLEPSY, SLEEP APNEA, INSOMNIA, EPILEPSY, HYPOTHALAMIC DYSFUNCTION GLIATECH, INC. 2002-09-10 US disclosed
US-6166060-A 1H-4(5)-substituted imidazole derivatives GLIATECH, INC. (US) 2000-12-26 US disclosed